The CoC Source - March 31, 2011
Saturday, May 14, 2011
Full-day workshop held in conjunction with the National Cancer Registrars’ Association Annual Meeting at Disney's Coronado Springs Resort., Orlando, FL
Registration for this workshop is through the National Cancer Registrars Association (NCRA), and the deadline to register is April 15, 2011. Space is limited so register today. For information and registration, log on to NCRA’s Web site at: http://www.ncra-usa.org/i4a/pages/index.cfm?pageID=3303
Watch for information regarding a workshop being organized for November 2011 which will be held at the American College of Surgeons headquarters in Chicago, IL.
Learn more about the National Accreditation Program for Breast Centers (NAPBC) components and standards, including changes to several recently added standards, by registering for the NAPBC Components and Standards Webinar scheduled for Tuesday, May 24, 2011, from 9–10 am (CDT). This Webinar will introduce new programs to the NAPBC components and the requirements outlined in each NAPBC standard. It will also provide NAPBC-accredited centers with new information related to changes made to the NAPBC standards and reflected in the 2011 NAPBC Standards Manual. There is a $50 registration fee.Register for the Webinar by going to http://eo2.commpartners.com/users/acs/session.php?id=6299
The NAPBC will host an exhibit at the following events:
American Society of Breast Surgeons (ASBS)
April 27 - May 1
Marriott Wardman Park Hotel
Oncology Nursing Society (ONS)
April 28 - May 1
Boston Convention and Exhibition Center
Those attending these meetings can ask questions and pick up an NAPBC Information Kit at the exhibit and see Ms. Burgin or Ms. Granville. To learn more about the NAPBC, visit http://www.accreditedbreastcenters.org, e-mail firstname.lastname@example.org, or call 312-202-5185.
The Council on Certification of National Cancer Registrars Association (NCRA) has prepared a fact sheet about the Certified Tumor Registrar (CTR®) credential, the CTR exam, and eligibility. With this increased knowledge, you can determine how current staff can earn the credential for compliance with Commission on Cancer’s Program Standards. NCRA’s certification board – the Council on Certification – develops and administers the CTR exam. The CTR credential demonstrates a requisite knowledge and professional competence within the cancer registry. The credential, first offered by NCRA in 1983, is nationally recognized in the recruitment and retention of registry personnel. Over 5,000 individuals have attained the CTR credential. For additional information about credential requirements and the exam, visit the NCRA website at http://www.ncra-usa.org/CTRprimer, which provides access to a pdf file.
Expert Voices to feature Society staff, volunteers, and others
ATLANTA –March 17, 2011– The American Cancer Society is launching a new resource to provide credible insight on cancer topics in easy-to-understand language. The American Cancer Society “Expert Voices” blog, available at www.cancer.org/expertvoices, will provide quality, timely cancer and health-related information from the experts of the American Cancer Society, as well as other knowledgeable clinicians, researchers, and authors.
“The goal of Expert Voices is to address emerging topics in cancer while also giving American Cancer Society staff and others a forum to interact directly with the public, and more broadly share their expertise,” said Terry Music, chief mission officer for the American Cancer Society. “We also hope it will increase the ongoing dialog between the American Cancer Society and the public.” Expert Voices postings, which will be updated at least once a week, are chosen based on the news cycle, interesting information coming out of the scientific community, and questions from the public that come to us via our various communications channels.
The centerpiece of SNM Center for Molecular Imaging Innovation and Translation (CMIIT) annual activities, (formerly the Molecular Imaging Center of Excellence) is a multi-modality molecular imaging symposium at the National Institutes of Health. This year, CMIIT is sponsoring “Breast Cancer Imaging and Treatment: State of the Art” to be presented April 21-22 at the Natcher Auditorium on the National Insitutes of Health campus in Bethesda, MD.
Our program committee includes Jason Lewis, MD; David Mankoff, MD, PhD; and Sandra Swain, MD, Together we have designed a two-day symposium that brings together individuals from multiple clinical and scientific disciplines associated with the diagnosis, staging, and treatment of patients with breast cancer. Specifically, the conference will address the need for synergism between diagnostic radiology and molecular imaging as applied to the care of breast cancer patients.
The speaker roster includes expert diagnostic radiologists, molecular imaging physicians and scientists, medical oncologists, surgeons, economists, and radiation oncologists. During the two-day meeting, we will review the current state of imaging in breast cancer, from the screening mammography controversy and advanced screening technology to local and distant staging and response to treatment. Breast cancer diagnosis and staging have been primarily the realm of diagnostic radiology, but with mammography, ultrasound, MRI, and CT scans, the importance of molecular imaging is increasing, and this symposium will address the integration of these previously separate disciplines. There will be lectures by clinical experts caring for breast cancer patients regarding local and systemic treatment admixed with the imaging lectures. These lectures will emphasize the role of molecular imaging in conjunction with radiology in enabling better treatment selection and evaluation and, importantly the ideal approach to assessing response to treatment. Timely topics on the agenda are cost effectiveness and radiation risk. Finally there will be a look into the future of molecular imaging in breast cancer and the potential of personalized, targeted care. The abstracts from our poster presenters can be found in the back of the current issue of the Journal of Nuclear Medicine. Part of the formula for these meetings is the participation of patient groups and other societies active in the respective areas and so far we are proud that the Society of Radiopharmaceutical Sciences, the Academy of Molecular Imaging, the Society for Molecular Imaging, the Radiological Society of North America, Hadassah, Susan G. Komen for the Cure, the Society of Women’s Health Research, and the Cancer Support Community have joined us in supporting this meeting.
Our meeting coincides with the spring cherry blossom season in Washington, and I hope you will consider bringing your family with you to our nation’s capital. Please visit our website for additional information at http://www.snm.org/breast2011. I look forward to seeing you there!
The Fourth International Symposium on Cancer Metastasis and the Lymphovascular System: Basis for Rational Therapy (http://www.cancermets.org)—May 12-14, 2011 at the InterContinental New York Barclay Hotel in New York City—will offer an extensive CME-program detailing the latest discoveries about the mechanisms of cancer metastasis and updating cutting-edge results from clinical trials. Biomarkers and their diagnostic and prognostic applications in metastatic cancer and their usefulness in molecular targeted therapy are a major focus, according to Symposium chairman Stanley P.L. Leong, MD, FACS, president of the Sentinel Node Oncology Foundation and chief of Cutaneous Oncology, and associate director of the Melanoma Program at California Pacific Medical Center, in San Francisco.
Sponsored by the National Cancer Institute (NCI), the Arizona Cancer Center, the Sentinel Node Oncology Foundation, AiM at Melanoma, and Sutter Pacific Medical Foundation, the Fourth International Symposium on Cancer Metastasis is designed to meet the educational needs of physicians and researchers involved in all oncology disciplines and subspecialties, including medical, surgical, and radiation oncologists; pathologists; and other translational-oriented laboratory scientists. Highlights include four mini-symposia: (1) New Paradigms of Cancer Treatment Based on Recent Results from the Sentinel Lymph Node Trials, including Armando Giuliano, MD, FACS; Monica Morrow, MD, FACS; and Donald Morton, MD, FACS; (2) Breast Cancer Update 2011, including Hope Rugo, MD; William Gradishar, MD; and Clifford Hudis, MD.; (3) Progression of Metastatic Melanoma: Implications for Treatment, including John Kirkwood, MD; Steven O’Day, MD; Dave Hoon, PhD; and Alexander Eggermont, MD, PhD; and 4) Meeting the Biologic Challenge of Colorectal Metastases, including Phillip Paty, MD; Nancy Kemeny, MD; and Michael D’Angelica, MD). The program includes cash awards for the five best metastasis-related abstracts submitted by young Investigators (under age 40) and Trainees (residents, fellows, or students). Authors of the three best abstracts submitted by General Attendees (investigators over 40, physicians who are not residents or fellows) will present their work. but with no cash award. To register or for more information, visit http://www.cancermets.org or call Paradigm Medical Communications, the Symposium’s ACCME-accredited CME-provider, at 845-398-5100, ext. 20.
Executive Training on Navigation and Survivorship: Finding Your Patient Focus
WHAT: The George Washington Cancer Institute's Center for the Advancement of Cancer Survivorship, Navigation and Policy (caSNP) is hosting its second Executive Training on Navigation and Survivorship: Finding Your Patient Focus. This two-day executive training program will equip decision-makers and program leaders with the tools needed to launch and sustain navigation and survivorship programs, two cornerstones of patient-centered cancer care. Participants will learn strategic planning techniques for developing, implementing, evaluating and sustaining patient navigation and survivorship programs. The training will combine distance-learning and traditional classroom instruction to fully maximize participants’ time. Participants will engage in a Webinar discussion that will lay the foundation for skill development during the two-day training. At the conclusion, participants will walk away with a business plan for either a survivorship or patient navigation program that will enhance the patient focus of their organization. For more information about the training please visit: http://www.gwumc.edu/caSNP/education.html
WHEN: April 13, 2011 (Webinar) and May 9-10, 2011 (in-person training)WHERE: The George Washington University, Washington D.C., 20037
National Cancer Registrars Week
April 11-15, 2011
Honoring the Central Role of Cancer Registrars in the Nation’s Cancer Prevention, Treatment and Research Programs
The Commission on Cancer regularly collaborates with over 50 member organizations in its mission to provide quality cancer care. This month we introduce the Centers for Disease Control and Prevention (CDC).
The Centers for Disease Control and Prevention (CDC) is a leader in nationwide efforts to ease the burden of cancer. Through the Division of Cancer Prevention and Control (DCPC), CDC works with national cancer control, state, tribal, and local health agencies, and other key groups to develop, implement, and promote effective strategies for preventing and controlling cancer. DCPC provides funding and technical support for state cancer registries, comprehensive cancer control programs (state and tribal cancer planning and implementation), and breast, cervical, and colorectal cancer screening programs for low income, uninsured and medically underserved individuals. DCPC conducts epidemiologic studies and applied research that is communicated to healthcare providers and the public to help them better understand factors that increase cancer risk and opportunities to prevent cancer.
The national cancer prevention and control programs currently funded by CDC include: The National Breast and Cervical Cancer Early Detection Program; The National Comprehensive Cancer Control Program; The Colorectal Cancer Control Program; and The National Program of Cancer Registries. In addition, the Division supports a number of mass mediated communication campaigns designed to meet public and health care provider information needs across the cancer continuum.
CDC will host the 2012 Cancer Conference in collaboration with other leaders in the field of Public Health. The conference will be held at the Omni Hotel at CNN Center in Atlanta located at 100 CNN Center Atlanta, GA, 30303. All sessions will take place at the hotel over a period of three days, February 13-16, 2012. The conference will include keynote speakers, invited plenary and topic presentations, abstracts and posters, all geared to address surveillance, prevention, early detection, treatment, rehabilitation, palliation, policy, communications and education, and program planning issues as relates to selected cancers and to comprehensive approaches to cancer prevention and control.
Recent Publications and/or Products:
A detailed description of the CDC Division of Cancer Prevention and Control, their partnerships, programs, scientists, research and recent publications can be found on their Web site: http://www.cdc.gov/cancer/
For more information on this organization, please contact:
Galen Cole, PhD, MPH, Associate Director for Communication Research and Evaluation, Atlanta, GA
Email: email@example.com | Web site: http://www.cdc.gov/cancer/
The Commission on Cancer regularly collaborates with over 50 member organizations in its mission to provide quality cancer care. This month we introduce the National Cancer Registrars Association (NCRA).
NCRA is a not-for-profit association representing cancer registry professionals and Certified Tumor Registrars (CTR). NCRA's primary focus is education and certification with the goal to ensure all cancer registry professionals have the required knowledge to be superior in their field. Worldwide, there are over 5,000 NCRA members and CTRs. Through various committees and affiliations with standard setting organizations, NCRA continues its mission and vision to serve as the premier education, credentialing and advocacy resource for cancer data professionals to improve lives through quality cancer data management.
Cancer registrars throughout the United States and abroad will join their colleagues, community leaders, and other medical professionals to observe the 15th annual National Cancer Registrars Week (NCRW), April 11-15, 2011. The 2011 theme, Cancer Registrars Pave the Way to a Cure, reflects cancer registrars’ role in compiling the critical information needed to support effective cancer treatment and research, with the ultimate goal of preventing cancer and finding a cure. The data is included in numerous publications including the Annual Report to the Nation on the Status of Cancer, a collaboration of the American Cancer Society, the Centers for Disease Control and Prevention, the National Cancer Institute, and the North American Association of Central Cancer Registries.
NCRA Office Staff consists of Lori Swain, Executive Director, Michael Hechter, Director of Membership and Credentialing, Nancy Allen, Operations Manager, Paula Spitler, Marketing Coordinator, and Alexis Mundis, Continuing Education and Member Services Coordinator.
NCRA Board of Directors includes Susan M. Koering, MEd, RHIA, CTR, President, Melanie Rogan, CTR, President Elect/Secretary, Inez Evans, BS, RHIT, CTR, Immediate Past President, Sarah Burton, CTR, Treasurer Sr., Kathy Dunaway, CTR, Treasurer Jr., Amy Bloom, MBA, MHA, CTR, Public Relations Director, Louise Schuman, MA, CTR, Professional Development Director, Dianne Cleveland, RHIA, CTR, Recruitment/Retention Director, Shannon Hart, CTR, Educational Director, Therese M. Richardson, RHIA, CTR, Advocacy Technical & Practice Board Director – East, Dana Lloyd, RHIA, CTR, Advocacy Technical & Practice Board Director – Midwest, Loretta (Lori) E. Travers, RHIT, CTR, Advocacy Technical & Practice Board Director - West
National Cancer Registrars Week (NCRW) April 11-15
NCRA 37 Annual Education Conference, Orlando, FL – May 15-18
2011 CTR Exam Testing Window: September 10-24
2006-2011 Strategic Plan: http://www.ncra-usa.org/files/public/SMPlan06.pdf
2010 Annual Report: http://www.ncra-usa.org/files/public/AnnualReport2010.pdf
Online Education Center/Discussion Forum: http://www.creducationcenter.org/ http://www.ncra-usa.org/i4a/bb/index.cfm
The Connection /Journal of Registry Management: http://www.ncra-usa.org/store
For more information on this organization, please contact:
1340 Braddock Place #203, Alexandria, VA 22314
Phone: 703-299-6640 | Fax: 703-299-6620
Email: firstname.lastname@example.org | Web site: http://www.ncra-usa.org
The Commission on Cancer regularly collaborates with over 50 member organizations in its mission to provide quality cancer care. This month we introduce the National Society of Genetic Counselors (NSGC).
The NSGC was incorporated in 1979.
The Society's Vision: Integrating genetics and genomics to improve health for all.
The Society's Mission: The National Society of Genetic Counselors advances the various roles of genetic counselors in health care by fostering education, research, and public policy to ensure the availability of quality genetic services. NSGC is currently led by President Karin Dent, MS, LCGC from the University of Utah, and governed by a twelve-member Board of Directors, with support from various Committees, Task Forces, and Special Interest Groups (SIGs).
NSGC promotes the professional interests of genetic counselors and provides a network for professional communications. Local and national continuing education opportunities and the discussion of all issues relevant to human genetics and the genetic counseling profession are an integral part of belonging to the NSGC.
NSGC’s current strategic initiatives are focused on increasing access to genetic counseling services through outreach and collaboration with physicians and other healthcare providers and advocacy and education with payers. NSGC is also committed to preparing and equipping our members with the knowledge and tools to proactively navigate the upcoming changes in the healthcare system and in genetics/genomics.
NSGC’s membership specializes in many different specialty areas and practice settings, providing support and genetic services to patients, physicians and other healthcare providers. The diversity of practice areas is evident in NSGC’s growing number of official special interest groups (SIGs), currently numbered at twenty. The largest of NSGC’s SIGs is the Familial Cancer Risk Counseling SIG (aka “The Cancer SIG”). The Cancer SIG is led this year by Jessica Everett, MS, CGC from the University of Michigan and Brittany Thomas, MS, CGC from the Mayo Clinic. The Cancer SIG specifically promotes communication between providers and affiliates of cancer genetic counseling services for the purpose of advancing the field of cancer genetic counseling.
NSGC’s primary education event is the Annual Education Conference (AEC), held each year in the fall. The 2011 AEC is scheduled for October 27 - 30 in San Diego, CA at the San Diego Marriott. Immediately preceding the AEC on October 26 is a day of Preconference Symposia. The Preconference Symposia are six, six-hour sessions on a specific topic, one being cancer-focused. This year’s cancer related Preconference Symposium involves pharmacogenetics, featuring a panel of experts within the field of Cancer Genetics. In addition, several educational break-out sessions at this year’s AEC will feature relevant hereditary cancer topics including Hereditary Diffuse Gastric Cancer, SNP-based Testing and Cancer Genetics, Prostate Cancer Genetics, and Fertility Issues related to Cancer.
NSGC also hosts a variety of year-round educational opportunities offered online. An online course is made available each summer and webinars are held throughout the year on various topics of interest to genetic counselors. Additional online courses on coding, cultural competence and clinical trials management are also available through NSGC.
Recent Publications and/or Products:
Several members of NSGC are actively involved in creating and maintaining Practice Guidelines, some of which involve collaborative efforts between NSGC and other organizations. Practice Guidelines for genetic cancer risk assessment and counseling, in collaboration with ASCO (American Society of Clinical Oncology) and ACMG (American College of Medical Genetics), are currently undergoing revisions and new Practice Guidelines regarding the evaluation and management for Lynch syndrome, in collaboration with CGA-ICC (Collaborative Group of the Americas on Inherited Colon Cancer), are in the final stages of development.
In addition the Cancer SIG published a document called, Practice Resources for Starting, Expanding, and Supporting a Cancer Genetics Program. Other helpful resources and publications are also available on the NSGC website: www.nsgc.org.
For more information on this organization, please contact:
Meghan Carey, Executive Director, 401 N. Michigan Avenue, Suite 2200, Chicago, IL 60611
Email: email@example.com | Web site: http://www.nsgc.org
The National Cancer Institute’s Division of Cancer Control and Population Sciences includes the Surveillance Research Program (SRP) and the Applied Research Program (ARP). One of the primary responsibilities of the SRP is the operation of the SEER Program. The SEER Program collects and publishes data from cancer registries covering 28 percent of the US population. SEER registries routinely collect data on patient demographics, tumor morphology, stage at diagnosis, first course of treatment, follow-up for vital status, and other related variables, which are used by researchers, clinicians, and the public. SEER provides training and education that is helpful to registrars seeking credentialing, and also leads workshops that provide advanced training in data collection and coding. SEER works with its surveillance partners to achieve data content and compatibility acceptable for pooling data and improving national estimates. Use of surveillance data for research is being improved through Web-based access to the data and analytic tools, and linking with other national data sources. Examples of SEER-specific data and resources available via the web include its Public Use Research Files and online bibliography. There are currently over 6 million records in the SEER database and almost 7,000 entries in the searchable bibliography.
ARP’s mission is to understand how and why cancer care and control activities in the United States influence patterns of care and trends in cancer incidence, morbidity, mortality and survival. A significant activity within ARP is the creation and maintenance of the SEER-Medicare database, the result of the biennial linkage of SEER data with Medicare enrollment and claims data. The database currently contains 1.6 million SEER patients found to be eligible for the Medicare. The Medicare claims include all covered services: hospitalizations, physician visits, outpatient clinic services, prescription drugs, and home health and hospice services. The data are longitudinal, allowing investigators to conduct studies on screening prior to a cancer diagnosis; patterns of care during the initial period of diagnosis and treatment; surveillance following diagnosis; and end- of-life care. The SEER-Medicare data can also be used to assess health disparities and the costs of cancer treatment. To date, there have been over 580 publications based on these data. A 2-day training course is offered annually and archives of training classes are available online.
Registration is now open for the following workshops/courses/events:
• SEER Workshops—“Advanced Topics for Registry Professionals,” and “SEER Prep.” May 19-20, 2011, The National Cancer Registrars Association (NCRA) Annual Conference, Orlando, FL (http://www.blsmeetings.net/2011SEERAdvancedTopics/objectives.cfm)
• SEER Workshops—“Basic and Advanced SEER*Stat Training Courses,” June 18-24, 2011, The North American Association of Central Cancer Registries (NAACCR) Annual Conference, Louisville, KY (http://www.naaccr.org/EducationandTraining/AnnualConference.aspx)
• SEER-Medicare Training Workshop. November 7-8, 2011. Rockville, MD (http://healthservices.cancer.gov/seermedicare/)
Recent Publications and/or Products:
The SEER Program has recently issued the following publications and resources:
• Kohler, AB, Ward, E, McCarthy, JB, et al. Annual Report to the Nation on the Status of Cancer, 1975-2007, Featuring Tumors of the Brain and Other Nervous System, The Journal of the National Cancer Institute (JNCI) (in press).
Recent SEER-Medicare publications include:
• Sima CS, Panageas KS, Schrag D. Cancer screening among patients with advanced cancer. JAMA. 2010 Oct 13;304(14):1584-91.
• Mariotto AB, Yabroff KR, Shao Y, Feuer EJ, Brown ML. Projections of the cost of cancer care in the United States: 2010-2020. J Natl Cancer Inst. 2011 Jan 19;103(2):117-28.
For more information on this organization, please contact:
Web site: http://seer.cancer.gov
Web site: http://healthservices.cancer.gov/seermedicare/